Primex Pharmaceuticals appoints Steen Vangsgaard as Head of Sales
Steen Vangsgaard has joined Primex Pharmaceuticals from Mylan Pharmaceuticals, where he was VP, Area Director. Prior to Mylan, Mr. Vangsgaard was EVP, Commercial Affairs at Bavarian-Nordic. He has extensive international leadership experience in growing sales and enhancing profitability of generics, branded pharmaceuticals and OTC portfolios. Additionally, he has background in business development and operational side of business.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180905005544/en/
Swiss pharmaceutical company Primex Pharmaceuticals AG announces the expansion of the leadership team with Mr. Steen Vangsgaard, appointed as Head of Sales to the Executive Management Team led by CEO Kari Sarvanto. (Photo: Business Wire)
“I look forward to working with our sales and distribution partners in anticipation of making ADV6209 available to children who face surgical intervention and emergency treatment. It is particularly gratifying to join Primex at a time where we are preparing to help reduce pre- and post-operative trauma in children and improve efficiency in trauma centres and operating theatres,” says Steen Vangsgaard.
At Primex, Mr. Vangsgaard is responsible for global sales. His first effort will be the sales force and launch of ADV6209 in the Nordics. He will be part of the Executive Team headed by CEO Kari Sarvanto in Zug, Switzerland.
Mr. Sarvanto comments: “I am pleased that Primex can attract top talent such as Steen. We are a fast growth company and with the impending launch of ADV6209, the first oral paediatric anaesthetic in Europe, for both premedication and procedural sedation, Steen will help us to accelerate our launches in Europe, internationally and in the US.”
About Primex Pharmaceuticals
Primex Pharmaceuticals aims to become the leading global innovative anaesthesia company, and to expand in paediatric pharmaceuticals.
A portfolio of strong, trusted anaesthesia products from propofol-based products acquired from Bayer, to a novel oral solution for paediatric procedural sedation, helping patients undergo a wide range of medical procedures. Primex Pharmaceuticals will continue to identify and acquire new medications that complete the ‘Triad of Anaesthesia’. The group includes a range of dental products and anaesthetics under the OGNA brand.
Primex Pharmaceuticals' global partner network operates in over 40 countries. The company is headquartered in Switzerland; all Primex products are manufactured in Europe. Primex Pharmaceuticals has proven underlying business operations and historical strong revenue growth.
See more at www.primexpharma.com
Primex Pharmaceuticals AG
Mr. Kari Sarvanto, Group CEO
Mobile: +41 796 162 694
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
SailPoint Survey Shows Employees’ Habits Expose Growing Risk Amid the Digital Transformation13.11.2018 09:01 | Tiedote
The results of the 10th Annual Market Pulse Survey from SailPoint Technologies Holdings, Inc. (NYSE: SAIL), the leader in enterprise identity governance, expose an alarming trend: despite an increased focus on cybersecurity awareness in the workplace, employees’ poor cybersecurity habits are getting worse, compounded by the speed and complexity of the digital transformation. Of the 1,600 global employees surveyed, 75% of respondents admitted to reusing passwords across accounts, including work and personal, compared to 56% who admitted to doing so in 2014, when SailPoint first posed the question. For more key findings, view the infographic, Balancing Efficiency and Security in Today’s Enterprises . Organizations are at varying stages of the digital transformation, and that evolution has presented an increasingly complex IT environment to manage securely. Yet this years’ Market Pulse Survey findings points to a workforce who are less committed to security best practices. This has not on
Biometric experts iProov support UK Home Office with technology to assure genuine presence13.11.2018 03:01 | Tiedote
iProov, a leading provider of biometric facial verification technology, today announced that it will play a key role in a multi-year contract with the UK Home Office for the provision of smartphone-based digital identity verification. This new capability will assist the UK Home Office in delivering secure, easy-to-use interactions with individuals in accordance with the digital services agenda. The app to support applications for the EU Exit Settlement Scheme includes this technology. The new digital service, which will be provided in partnership with immigration and border management company WorldReach Software with support from Dutch contactless document specialist ReadID, allows secure enrolment onto Home Office services using a smartphone app. The process involves biometric matching of the user’s selfie against the image read from a user’s passport chip, using iProov’s unique Flashmark technology to provide robust liveness detection. iProov is unique in its ability to ‘assure genui
Project Management Institute Launches New Reports on Navigating the New Normal of Disruptive Technologies During Seventh Annual PMO Symposium®12.11.2018 19:43 | Tiedote
Project Management Institute (PMI) today unveiled three thought leadership reports focused on navigating the new normal of disruptive technologies. The new reports were released during the organization’s seventh annual PMO Symposium® in Washington D.C., where more than 650 of the world’s top project management office (PMO) executives, organizational leaders and senior decision makers have gathered to discuss how disruptive technologies—such as cloud solutions, internet of things (IoT) and artificial intelligence (AI)—have changed the way organizations do business and transformed entire industries. Throughout 2018, PMI and partners, have been exploring disruptive technologies and how organizations are using them to achieve their goals in these changing times. While no one single factor can drive benefits realization, leading organizations understand that proven project management practices lead to greater success and less waste. Produced in partnership with Accenture, PMI’s report — For
Separate Independent Studies Found that PREVENA™ Therapy Reduced Complications Following Breast Cancer Surgery and Breast Reconstruction12.11.2018 17:00 | Tiedote
KCI, an Acelity Company, announced today that recently published data stemming from two studies demonstrate that closed incision negative pressure therapy (ciNPT) with the PREVENA™ Incision Management System reduced postsurgical wound complication potential in patients recovering from oncological breast surgery and breast reconstruction, respectively. One study titled, “The Impact of Closed Incision Negative Pressure Therapy on Postoperative Breast Reconstruction Outcomes,” showed that patients who received ciNPT with the PREVENA™ System had significantly lower rates of overall complications and returns to the operating room compared to those in the standard of care (SOC) for incision management after breast reconstruction post-mastectomy group. In addition, patients in the PREVENA™ Therapy group overall had a shorter mean time to complete removal of all drains than the SOC group, averaging 9.9 days versus 13.1, respectively.1 In a separate study titled, “Closed Incision Negative Press
Itron Invites Innovators to Participate in Smart City Challenge12.11.2018 16:45 | Tiedote
Itron, Inc. (NASDAQ: ITRI) is calling for hardware and software vendors to submit their products and solutions to the inaugural Itron Smart City Challenge. IoT solution providers will compete for the chance to work with leading smart cities, including Glasgow and the City of London, to deploy breakthrough solutions. Applications are due by Jan. 4, 2019. Participants are invited to develop solutions to address challenges defined by the participating cities. Glasgow: Improve travel choices and experience during events in the city while promoting the overall city center offer The City of Glasgow is one of the world’s top sporting cities and a major destination for conferences and concerts. Many thousands of people come to the city on a regular basis to experience its year-round calendar of events. However, this brings significant challenges in getting people safely and conveniently around the city to their location. It also impacts residents and particularly, the public transport system.
US-Based Lineage Logistics Acquires UK Cold Storage, Frozen Food and Logistics Service Provider Yearsley Group12.11.2018 15:00 | Tiedote
Lineage Logistics Holdings, LLC (“Lineage” or the “Company”), the world’s most innovative and trusted provider of temperature-controlled supply chain solutions, today announced it has acquired Yearsley Group Limited (“Yearsley”), a leading temperature-controlled logistics service provider and frozen food distributor in the UK. Financial terms of the transaction were not disclosed. “Yearsley has demonstrated a strong commitment to developing longstanding, bespoke customer relationships that is consistent with how we do business at Lineage. Bringing Yearsley into the Lineage family enables us to better serve customers in the UK market and further reinforces our international logistics capabilities,” said Greg Lehmkuhl, President and Chief Executive Officer of Lineage Logistics. “Our acquisition by Lineage is a tremendous opportunity for Yearsley customers and employees alike,” said Jonathan Baker, Chief Executive of Yearsley Group. “Lineage’s commitment to innovation and service is unmat
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme